Names in the programme record: Sanjeev Gupta and Richard Boyle
Profile completeness92%
Comprehensive · Missing faculty profile
DECISION SUMMARY
Key facts at a glance
Eligibility
Entry requirements published; check international conditions
Funding
Approximately AUD 216,339 per year in the cited AOA profile; confirm the appointed-year rate directly
Deadline
31 December 2026
Duration
12 months; timing is negotiable, with the published cycle running 1 August to 31 July
Hands-on
Unclear — confirm privileges
Clinical exposureComplex primary and revision hip and knee arthroplasty through all phases of care, a service reporting more than 800 joint replacements per year, orthopaedic oncology with arthroplasty management and multidisciplinary tumour meetings, trauma and on-call work
Participation levelClinical participation and hands-on restrictions must be confirmed directly with the host.
INTERNATIONAL APPLICANT CHECK
Can an international surgeon apply?
≈Partially published
International applicants
Applicants with an overseas qualification equivalent to FRACS may be eligible; exact recognition, registration and visa requirements should be confirmed directly.
?Confirm directly with host
Clinical role
Clinical or combined training pathway; exact duties remain appointment-specific. Hands-on participation and operative restrictions are not explicitly published.
≈Partially published
Medical registration
An eligible specialist IMG undertaking up to 24 months of advanced training may use the Medical Board of Australia's short-term training pathway. This requires primary-source verification, a confirmed position, specialist-college assessment, supervised-practice documents and limited registration for postgraduate training or supervised practice.
✓Published by official source
Language
Australian medical registration applicants must meet the current Ahpra English-language skills standard through an accepted education or test pathway; the standard includes IELTS Academic, OET, PTE Academic, TOEFL iBT and Cambridge routes with current score and validity rules.
—Not published
Visa or work authorisation
Not published; international applicants should confirm work-authorisation requirements directly.
DATA QUALITY & AVAILABILITY79% of core application fields verifiedChecked 23 Sep 2026 · Next scheduled editorial review: 2027-04-01
✓ programme title✓ institution / department✓ city and country✓ programme classification✓ subspecialty✓ duration✓ commencement / intake✓ funding✓ eligibility✓ international eligibility✓ language✓ registration✓ deadline✓ application process✓ required documents✓ official contact✓ faculty✓ verified faculty photograph✓ verified institution logo✓ official source✓ institutional source✓ accreditation / organisation source✓ verification date— Current availability unconfirmed · current availability unconfirmed— positions · not published by the cited official source— benefits · not published by the cited official source— accommodation / relocation · not published by the cited official source— visa / work authorisation · not published by the cited official source— application portal · not applicable to this pathway
APPLICATION TIMELINE & CONTACT
Plan the application
Application deadline31 December 2026
Commencing date1 August
Application route / cycleApplications are received 18 months ahead with a cut-off of 31 December, 18 months before the fellowship commences (31 December 2026 corresponds to an August 2028 start)
Recognised four-year orthopaedic training programme including significant trauma experience
FRACS or equivalent qualification, or board eligibility
Application documents
Published by official source
Detailed curriculum vitae
Names of three referees with whom the applicant has worked
PROGRAM OVERVIEW
What this program offers
A one-year RPA fellowship in complex primary and revision arthroplasty with orthopaedic oncology, multidisciplinary tumour work, trauma and on-call duties. The AOA profile publishes a recurring application timetable, but no current vacancy or cycle year is confirmed.
Intended for: Surgeons who have completed recognised four-year orthopaedic training with significant trauma experience and hold FRACS or an equivalent qualification, or are board eligible.
HOST INSTITUTION
About Royal Prince Alfred Hospital
Royal Prince Alfred Hospital's current orthopaedic research page identifies Sanjeev Gupta as education lead and lower-limb arthroplasty research lead and Richard Boyle as bone and soft-tissue tumour research lead. Australian registration pathway: medicalboard.gov.au ↗. English standard: ahpra.gov.au ↗.
Help us understand which pages are useful. Google Analytics stays off unless you allow it. Declining does not affect access to OrthoFellow. Privacy policy
